Public Profile

KIRSCH PHARMA ESPAÑA

KIRSCH PHARMA ESPAÑA, a prominent subsidiary of KIRSCH PHARMA, is headquartered in Italy and operates extensively across Spain and other key European markets. Established in 1994, the company has carved a niche in the pharmaceutical industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and excipients. KIRSCH PHARMA ESPAÑA is renowned for its innovative solutions tailored to meet the evolving needs of the pharmaceutical sector, focusing on sustainability and regulatory compliance. With a commitment to excellence, the company has achieved significant milestones, including certifications that underscore its market position as a trusted partner in drug formulation. Through its dedication to quality and customer-centric approach, KIRSCH PHARMA ESPAÑA continues to enhance its reputation as a leader in the pharmaceutical landscape, providing unique products that support the health and well-being of patients worldwide.

DitchCarbon Score

How does KIRSCH PHARMA ESPAÑA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

KIRSCH PHARMA ESPAÑA's score of 13 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

10%

Let us know if this data was useful to you

KIRSCH PHARMA ESPAÑA's reported carbon emissions

KIRSCH PHARMA ESPAÑA currently does not have available carbon emissions data for recent years, nor do they have specified reduction targets or climate pledges. This absence of specific emissions figures and commitments suggests that the company may still be in the early stages of formalising its climate strategy. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, often through initiatives aimed at improving energy efficiency and transitioning to renewable energy sources. As KIRSCH PHARMA ESPAÑA develops its climate commitments, it will be essential for them to establish measurable targets and report on their emissions to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. KIRSCH PHARMA ESPAÑA's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for KIRSCH PHARMA ESPAÑA is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

KIRSCH PHARMA ESPAÑA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers